Kliniken & Institute ... Institute Pathologisches Institut... Abteilungen Neuropathologie Forschung Publikationen 2008 ...

Publikationen 2008

The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin.

Siegelin MD, Reuss DE, Habel A, Herold-Mende C, von Deimling A.

Mol Cancer Ther. 2008 Nov;7(11):3566-74.

Analysis of the IDH1 codon 132 mutation in brain tumors.

Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A.

Acta Neuropathol. 2008 Dec;116(6):597-602. Epub 2008 Nov 5.

Expression of glucose transporter 1 is associated with loss of heterozygosity of chromosome 1p in oligodendroglial tumors WHO grade II.

Stockhammer F, von Deimling A, Synowitz M, Blechschmidt C, van Landeghem FK.

J Mol Histol. 2008 Oct;39(5):553-60. Epub 2008 Aug 26.

Accumulation of genomic aberrations during clinical progression of medulloblastoma.

Korshunov A, Benner A, Remke M, Lichter P, von Deimling A, Pfister S.

Acta Neuropathol. 2008 Oct;116(4):383-90. Epub 2008 Aug 15.

EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy.

Holtkamp N, Malzer E, Zietsch J, Okuducu AF, Mucha J, Mawrin C, Mautner VF, Schildhaus HU, von Deimling A.

Neuro Oncol. 2008 Dec;10(6):946-57. Epub 2008 Jul 23.

The evolution of our understanding on glioma.

Martin-Villalba A, Okuducu AF, von Deimling A.

Brain Pathol. 2008 Jul;18(3):455-63. Epub 2008 Mar 26. Review.

Yes and PI3K bind CD95 to signal invasion of glioblastoma.

Kleber S, Sancho-Martinez I, Wiestler B, Beisel A, Gieffers C, Hill O, Thiemann M, Mueller W, Sykora J, Kuhn A, Schreglmann N, Letellier E, Zuliani C, Klussmann S, Teodorczyk M, Gröne HJ, Ganten TM, Sültmann H, Tüttenberg J, von Deimling A, Regnier-Vigouroux A, Herold-Mende C, Martin-Villalba A.

Cancer Cell. 2008 Mar;13(3):235-48.

Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR.

Lorente A, Mueller W, Urdangarín E, Lázcoz P, von Deimling A, Castresana JS.

BMC Cancer. 2008 Feb 25;8:61.

Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.

Tallen UG, Truss M, Kunitz F, Wellmann S, Unryn B, Sinn B, Lass U, Krabbe S, Holtkamp N, Hagemeier C, Wurm R, Henze G, Riabowol KT, von Deimling A.

J Neurooncol. 2008 Jan;86(1):23-30. Epub 2007 Sep 1.

Die neue WHO-Hirntumor-Klassifikation aus dem Jahr 2007.

Hartmann C, Wiestler OD

Brainstorm 2008 1:14-17

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.

Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, Toedt G, Wittmann A, Kratz C, Olbrich H, Ahmadi R, Thieme B, Joos S, Radlwimmer B, Kulozik A, Pietsch T, Herold-Mende C, Gnekow A, Reifenberger G, Korshunov A, Scheurlen W, Omran H, Lichter P.

J Clin Invest. 2008 May;118(5):1739-49.

Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.

Inta I, Frauenknecht K, Dörr H, Kohlhof P, Rabsilber T, Auffarth GU, Burkly L, Mittelbronn M, Hahm K, Sommer C, Schwaninger M.

J Neurol Sci. 2008 Dec 15;275(1-2):117-20. Epub 2008 Sep 14.

A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy.

Posch MG, Posch MJ, Geier C, Erdmann B, Mueller W, Richter A, Ruppert V, Pankuweit S, Maisch B, Perrot A, Buttgereit J, Dietz R, Haverkamp W, Ozcelik C.

Mol Genet Metab. 2008 Sep-Oct;95(1-2):74-80. Epub 2008 Aug 3.

Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma.

Siegelin MD, Habel A, Gaiser T.

Neurosci Lett. 2008 Dec 19;448(1):161-5. Epub 2008 Oct 17.

TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin.

Gaiser T, Becker MR, Habel A, Reuss DE, Ehemann V, Rami A, Siegelin MD.

Neurosci Lett. 2008 Sep 12;442(2):109-13. Epub 2008 Jul 10.